ArticleScientific reports2025
Hepatitis A epidemics in Japan, France, and Thailand from 2007 to 2021, highlighting a post-COVID-19 decline.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Single-Center Retrospective Study of Hospitalized Hepatitis A Cases in Southern Bulgaria, 2015-2023.Healthcare (Basel, Switzerland) · 2026Article
- Influence of Both La Nina and Island Isolation During COVID-19 on the Epidemiology of Infectious Diseases in New Caledonia.Epidemiologia (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatitis A infection is an acute hepatitis disease transmitted through contaminated water, food, and sexual contact, especially among men who have sex with men (MSM). This retrospective cohort study analyzed trends in hepatitis A infection in Japan, France, and Thailand from 2007 to 2021 to investigate varied epidemic trends including the MSM pandemic and the COVID-19 pandemic under different public health conditions. We analyzed annual and monthly number of cases using the national surveillance databases of Japan, France, and Thailand. We statistically evaluated the decrease in hepatitis A after the COVID pandemic. Hepatitis A average incidence in Japan, France, and Thailand was 0.21, 1.79, and 0.75, respectively. Outbreaks were recorded in 2010, 2014, and 2018 for Japan, 2009 and 2017 for France, and 2012 and 2017 for Thailand. In 2012, a hepatitis A outbreak was recorded at an ice manufacturing factory in Thailand. In Japan, in 2014, 80.5% of cases were transmitted by contaminated seafood or water. Hepatitis A increased during 2017-2018 (324% in 2018 Japan, 489% in 2017 France, 166% in Thailand), possibly linked to the global MSM pandemic. After the COVID-19 pandemic, the cases significantly decreased in all three countries (p < 0.001). The characteristics of hepatitis A epidemic may reflect the activities of people, including high-risk groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.